The Huberman Lab
The Huberman Lab

Essentials: Erasing Fears & Traumas Using Modern Neuroscience

In this Huberman Lab Essentials episode, I explore the neuroscience of fear and trauma and how to effectively process and eliminate traumatic responses. I explain why successful fear treatment requires both extinction of the old fearful response and replacement with a new positive association—not ju

Featured Speakers

Scicomm Media HostAndrew Huberman Guest

Topics Discussed

Episode Summary

Executive Summary: The episode explains fear as a learned threat reflex built from stress, anxiety, memory, autonomic arousal, and top-down meaning-making. Huberman outlines the neural circuitry (amygdala, HPA axis, prefrontal cortex) and emphasizes that lasting recovery from trauma requires not just extinction of fear, but replacement with new positive associations. He reviews behavioral, drug, and self-directed tools for reducing fear and PTSD symptoms.

Main Topics: Biology of fear, stress, anxiety, and trauma (Priority: 5/5): Fear is framed as an emotion arising from body sensations, thoughts, and memory. Stress and anxiety are components of fear, while trauma is fear that becomes maladaptively embedded and reactivated. Neural circuits of the threat reflex (Priority: 5/5): The amygdala is presented as the final common pathway for threat responses, with inputs from sensory and memory systems and outputs to the hypothalamus, adrenals, and reward-related dopamine circuits. HPA axis and autonomic arousal (Priority: 5/5): The sympathetic/parasympathetic balance and the hypothalamic-pituitary-adrenal axis explain how fear rapidly mobilizes the body and can produce long-lasting hormonal effects that influence gene expression. Fear learning and extinction through conditioning (Priority: 4/5): Classical conditioning is used to explain how single or repeated experiences can create durable fear memories, sometimes generalizing to places, people, or situations. Therapies for trauma and fear reduction (Priority: 5/5): Prolonged exposure therapy, cognitive processing therapy, and CBT are described as effective because they reduce physiological reactivity through repeated detailed recounting and new narrative formation. Drug-assisted and self-directed interventions (Priority: 4/5): Ketamine-assisted psychotherapy, MDMA-assisted psychotherapy, cyclic hyperventilation, and supportive lifestyle/supplement approaches are discussed as ways to alter arousal, perspective, and memory reconsolidation. Role of social connection and baseline health (Priority: 3/5): Trusting social connection, sleep, hydration, nutrition, and select supplements are described as foundational supports that can improve resilience and reduce anxiety load.

Key Arguments: Fear is not identical to stress or anxiety; it incorporates elements of both, but can also become trauma when the response is reactivated in maladaptive contexts. The amygdala is central to the threat reflex, integrating sensory and memory inputs and driving autonomic and behavioral responses. The HPA axis creates both immediate alertness and longer-lasting hormonal effects that can influence gene expression and help embed fear memories. Fear and trauma are fundamentally memory problems: some memories are protective, while others become dangerous because they overgeneralize or persist unnecessarily. Fear cannot simply be erased; effective treatment requires reducing the original physiological charge and replacing it with a new positive association or narrative. Detailed repeated recounting in therapy reduces autonomic arousal over time, making exposure-based approaches effective. Ketamine and MDMA may work by changing the emotional state during trauma recall, enabling new associations to attach to old memories. Cyclic hyperventilation may deliberately induce short-term stress to facilitate recalibration, though it should be approached cautiously, especially in those with panic or anxiety disorders. Trusting social connection supports recovery by engaging circuits and chemicals relevant to fear regulation and resilience. Supplementation and sleep support may help overall anxiety burden, but they are adjunctive rather than primary trauma treatments.

Data Points: HPA axis components: 3-part system - Hypothalamus, pituitary, and adrenal glands together drive the stress response and alertness. Amygdaloid complex subdivisions: 12-14 areas - The amygdala is described as a larger complex with multiple subregions. Therapy modalities named: 3 - Prolonged exposure therapy, cognitive processing therapy (CPT), and cognitive behavioral therapy (CBT). Breathing protocol duration: 5 minutes/day - Cyclic hyperventilation protocol used to intentionally increase autonomic arousal. Breath hold interval: 25-30 breaths - During cyclic hyperventilation, a full exhale and breath hold is done after about this many breaths. Breath hold duration: 25-60 seconds - Approximate length of the full-exhale hold during cyclic hyperventilation. Saffron dose: 30 mg - Oral saffron is reported to reduce anxiety in human studies. Saffron studies: 12 studies - Human trials cited for saffron’s anxiolytic effects. Inositol dose: 18 grams - Dose described as producing notable anxiety reduction over about one month. Inositol treatment duration: 1 month - Time frame needed before symptom improvement is expected. Function tests: 100+ biomarkers - Function Health is described as offering comprehensive lab testing across health domains. Function waitlist: 250,000+ people - Current waitlist size mentioned for Function Health.

Pivotal Quotes: "We can't just eliminate fears, we actually have to replace fears with a new positive event." — Andrew Huberman: Core thesis on fear extinction and memory replacement. "There's no negotiating what fear feels like, there's only negotiating what it means." — Andrew Huberman: Explains the role of prefrontal cortex, narrative, and meaning-making in fear regulation. "The amygdala is essential for the threat response." — Andrew Huberman: Summary of the amygdala’s central role in the fear circuit.

Implications: Listeners can use the episode to understand fear as a modifiable neural-memory process and to choose interventions that match the mechanism: exposure, narrative rewiring, social support, and carefully selected adjuncts rather than simple suppression.

🔓 Sign Up for Unlimited Episode Search

About The Huberman Lab

The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

View all episodes from The Huberman Lab